实用肿瘤学杂志 ›› 2014, Vol. 28 ›› Issue (5): 410-414.doi: 10.11904/j.issn.1002-3070.2014.05.006

• 论著 • 上一篇    下一篇

胃食管结合部癌Her-2基因扩增及蛋白表达与临床病理关系

韩鸿彬,韩保卫,李朝辉,董帅军,刘帅锋   

  1. 郑州大学附属洛阳中心医院胃肠胰腺外科(洛阳 471009)
  • 收稿日期:2014-06-26 出版日期:2014-10-28 发布日期:2014-10-28
  • 通讯作者: 韩鸿彬,E-mail:hanhb132@sina.com
  • 作者简介:韩鸿彬,男,(1970-),硕士,副主任医师,从事胃肠道肿瘤的临床及基础研究

The association of Her-2 amplification and overexpression with clinicopathological features in adenocarcinoma of the gastroesophageal junction

HAN hongbin,HAN baowei,LI zhaohui,Dong shuaijun,LIU shuaifeng   

  1. Department of Gastrointestinal Pancreatic Surgery,The Affiliated Luoyang Central Hospital of Zhengzhou University,Luoyang 471009,China
  • Received:2014-06-26 Online:2014-10-28 Published:2014-10-28

摘要: 目的 通过检测表皮生长因子-2(Her-2)在胃食管结合部癌中的蛋白表达和基因扩增情况,探讨其与胃食管结合部癌患者的临床病理关系。方法 采用免疫组织化学法(IHC)和荧光原位杂交技术(FISH)检测80例手术切除的胃食管结合部癌组织中Her-2的蛋白表达和基因扩增情况,并分析与胃食管结合部癌的病理分化程度、浸润深度、临床分期和淋巴结转移的关系。结果 应用FISH技术检测显示在胃食管结合部癌组织中Her-2的蛋白阳性表达率为22.5%,应用IHC技术检测其在癌组织表达率为15%,Her-2基因扩增和蛋白阳性表达与胃食管结合部癌的分化程度和临床TNM分期有关(P<0.05),而与年龄、性别和浸润深度及淋巴结转移无相关性。结论 Her-2蛋白过表达和基因扩增是胃食管结合部癌患者的一个预后指标,与其发生发展有关,联合检测Her-2蛋白表达水平及基因扩增程度对于胃食管结合部癌的治疗和预后评估有一定指导意义。

Abstract: Objective To study the protein expression and gene amplification of human epidermal growth factor receptor-2(Her-2)in adenocarcinoma of the gastroesophageal junction and its association with the clinicopathological features.Methods Immunohistochemical method and fluorescence in situ hybridization(FISH)were used to detect Her-2 expression and gene amplification in 80 surgically resected gastroesophageal junction cancer tissue.We further analyzed the relationship between the gastroesophageal junction cancer histological differentiation,as well as depth of invasion,clinical stage and lymph node metastasis.Results Her-2 amplification of gastroesophageal junction carcinoma by FISH was 22.5%,while the overexpression by IHC was 15%.Her-2 gene amplification and protein overexpression were correlated with the differentiation,clinical TNM stage,invasive depth and lymph node metastasis of the carcinoma(all P<0.05).Her-2 expression was not associated with the patients age,gender,invasive depth and lymph node metastasis(P<0.05).Conclusion Her-2 protein expression and gene amplification may be a prognostic indicator for the patients with gastroesophageal junction cancer.The joint detection of Her-2 protein expression level and the gene amplification can guide the prognosis and therapy for adenocarcinoma of the gastroesophageal junction.

中图分类号: